Fresenius Medical Care AG ADR (FMS)
NYSE: FMSHealth CareMisc Health and Biotechnology ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
FMS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $10.61B
- P/E (TTM)
- 11.82
- Forward P/E
- 7.77
- EPS (TTM)
- $1.73
- Dividend yield
- 7.29% ($1.49)
- Ex-dividend date
- May 22, 2026
- 52-week range
- 20.00 – 26.42
- Day range
- 20.38 – 20.72
- Volume / Avg
- 1.34M / 1.17M
- Beta
- —
- Shares outstanding
- 519.02M
52-week range
FMS stock today
Shares of Fresenius Medical Care (FMS) finished higher on Nov 20 at $20.44, a gain of 1.54% or $0.31 per share, versus the S&P 500's 3.70% decline. At this level, FMS sits near the bottom of its 52-week range of $20.00 to $26.42: 22.6% below the high, set on Aug 3, 2026 and 2.2% above the low. FMS is down 14.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 12.7%.
At 11.8x trailing earnings, Fresenius Medical Care trades below the peer-group median of 24.5x. Its forward P/E of 7.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Fresenius Medical Care pays an annual dividend of $1.49 per share, a 7.29% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Fresenius Medical Care
Company profileFresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Mr. Shervin J. Korangy
- Headquarters
- Bad Homburg
- Employees
- 106,291
- Website
- freseniusmedicalcare.com
Financial highlights
Full financialsIn fiscal 2013, Fresenius Medical Care generated $4.97 billion in revenue, down 64.0% from fiscal 2012, the first decline in the 7 years shown. Net income was $1.11 billion (-6.5% year over year), for a net margin of 22.3% versus a median of 8.3% in the prior 5 years. Gross margin was 95.3% (up from 33.3%) and operating margin 45.4%.
| Fiscal year | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|
| Revenue | $4.97B | $13.80B | $12.57B | $11.84B | $11.25B |
| Growth | -63.98% | +9.78% | +6.13% | +5.31% | +5.99% |
| Net income | $1.11B | $1.19B | $1.07B | $978.52M | $891.14M |
| EPS (diluted) | $3.65 | $3.87 | $3.51 | $3.24 | $2.99 |
Analyst forecast
ForecastConsensus (7 analysts)
hold
Avg. price target
$21.99+7.58%
- Strong buy 1
- Buy 0
- Hold 3
- Sell 1
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $0.64 vs —
Dividends
Dividend history- Annual dividend
- $1.49
- Dividend yield
- 7.29%
- Last payment
- $0.872
- Ex-dividend date
- May 22, 2026
FMS news
All FMS news- Fresenius Plans 13.4 Mln-Share Sale To Cut Medical Care Stake To 20%NasdaqFMS, HEI.A
- Fresenius Medical Care AG Places Bond with a Volume of 500 million EurosNasdaq
- Fresenius Medical Care AG 2026 Q3 - Results - Earnings Call PresentationSeeking Alpha
- What Fresenius Medical Care AG & Co. KGaA (FMS) Said on Its Q3 Earnings CallNasdaq
- Fresenius Medical Care AG (FMS) Q3 2026 Earnings Call TranscriptSeeking Alpha
- Fresenius Medical Care AG Reports Q3 2026 Results and Narrows Full Year OutlookNasdaq
- Fresenius Medical Q3 Profit Falls; Revises FY26 Operating Income Outlook, Backs Revenue ViewNasdaq
- Fresenius, WuXi Enter Development Agreement To Expand Biosimilars PipelineNasdaq
Fresenius Medical Care peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DVADaVita Inc. | 161.03 | +3.00% | $10.13B | vs FMS |
| SHCSotera Health Company | 15.91 | -1.85% | $4.54B | vs FMS |
| PGNYProgyny Inc. | 35.71 | +0.73% | $2.63B | vs FMS |
| AGLagilon health inc. | 90.24 | +0.83% | $1.52B | vs FMS |
| VMDViemed Healthcare Inc. | 8.52 | -1.05% | $322.85M | vs FMS |
| PARKPark Dental Partners Inc. | 17.03 | -6.79% | $94.26M | vs FMS |
| CCELCryo-Cell International Inc. | 4.15 | 0.00% | $33.46M | vs FMS |
| MGRXMangoceuticals Inc. | 0.1236 | -7.55% | $2.75M | vs FMS |
Indexes, lists and sector
Fresenius Medical Care stock FAQ
What is Fresenius Medical Care's stock price today?
FMS last traded at $20.44 as of Nov 20, 4:00 PM EST, up 1.54% on the day. Prices are delayed at least 15 minutes.
Does Fresenius Medical Care pay a dividend?
Yes. Fresenius Medical Care pays $1.49 per share annually, a 7.29% yield. The most recent dividend of $0.872 had an ex-dividend date of May 22, 2026.
What is FMS's P/E ratio?
FMS trades at a trailing P/E ratio of 11.82 and a forward P/E of 7.77, compared with a median of 24.5 for its closest peers.
Who is Fresenius Medical Care's CEO?
Mr. Shervin J. Korangy is the chief executive officer of Fresenius Medical Care AG ADR, which has about 106,291 employees.
Has FMS ever split its stock?
Yes. The most recent FMS stock split was a 2-for-1 split on Dec 4, 2012.
What is the FMS 52-week high?
The 52-week high for FMS is $26.42 and the 52-week low is $20.00. The stock is currently 22.6% below its high.